ClinicalTrials.Veeva

Menu

3D Imaging of Neonatal Faces

S

Sharp HealthCare

Status

Completed

Conditions

Nose Deformities, Acquired

Treatments

Other: 3D Scan of nares

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT02603796
3D Imaging in neonates

Details and patient eligibility

About

Facial scans of newborns will be performed before and after implementation of respiratory support devices such as nasal CPAP. 3D scanned images will be processed by Fisher & Paykel Healthcare Limited. Images will be analyzed for changes or distortion in nasal structure.

Full description

Any newborns admitted to the neonatal intensive care unit at Sharp Mary Birch Hospital for Women and Newborns between 24-42 weeks CGA with parental informed consent are eligible. 3D scanned image will be obtained prior to implementation of nasal support devices and after nasal support devices. Fisher & Paykel Healthcare Limited will analyze the 3D images and observations will be made for changes in nasal structure or distortion.

Enrollment

18 patients

Sex

All

Ages

24 to 42 weeks old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Infants between 24 and 42 weeks corrected gestational age (inclusive) born at Sharp Mary Birch NICU,
  • Signed informed consent form

Exclusion criteria

  • Nasally intubated infants
  • Infants with craniofacial abnormalities

Trial design

18 participants in 1 patient group

Newborns requiring ncpap
Description:
3D scan of nares will be performed before and after administration of NCPAP for infants with Corrected Gestational Age greater than or equal to 24 weeks and less than or equal to 42 weeks.
Treatment:
Other: 3D Scan of nares

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems